Evidence map›Paper›PMID 35627994›Full record

ArticleHealthcare (Basel, Switzerland)2022

Uterine Fibroids and Pregnancy: A Review of the Challenges from a Romanian Tertiary Level Institution.

Mihaela Camelia Tîrnovanu, Ludmila Lozneanu, Ştefan Dragoş Tîrnovanu, Vlad Gabriel Tîrnovanu, Mircea Onofriescu, Carmen Ungureanu, Bogdan Florin Toma, Elena Cojocaru

Open access · goldAbstract read
In one paragraph

Article in Healthcare (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
4.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 27 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Mihaela Camelia TîrnovanuDepartment of Mother and Child Medicine, "Grigore. T. Popa" University of Medicine and Pharmacy, 700115 Iasi, Romania.
Ludmila LozneanuDepartment of Morphofunctional Sciences I, "Grigore T. Popa" University of Medicine and Pharmacy, 700115 Iasi, Romania.
Ştefan Dragoş TîrnovanuDepartment of Surgery II, "Grigore T. Popa" University of Medicine and Pharmacy, 700115 Iasi, Romania.
Vlad Gabriel TîrnovanuDepartment of Mother and Child Medicine, "Grigore. T. Popa" University of Medicine and Pharmacy, 700115 Iasi, Romania.
Mircea OnofriescuDepartment of Mother and Child Medicine, "Grigore. T. Popa" University of Medicine and Pharmacy, 700115 Iasi, Romania.
Carmen UngureanuDepartment of Morphofunctional Sciences I, "Grigore T. Popa" University of Medicine and Pharmacy, 700115 Iasi, Romania.
Bogdan Florin TomaDepartment of Mother and Child Medicine, "Grigore. T. Popa" University of Medicine and Pharmacy, 700115 Iasi, Romania.
Elena CojocaruDepartment of Morphofunctional Sciences I, "Grigore T. Popa" University of Medicine and Pharmacy, 700115 Iasi, Romania.ORCID 0000-0001-7859-840X
Clinical Emergency Hospital Bucharest · ROGrigore T. Popa University of Medicine and Pharmacy · RO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

objectivesUterine fibroids are relatively common in reproductive-age women and are directly linked to pregnancy. There are many debates about performing a myomectomy at the same time as a caesarian section (CS) in such cases due to the risk of a hemorrhage. Our study aims to investigate fibroid features and their evolution in pregnancy, complications of a myomectomy during CS and maternal and fetal obstetric outcomes of pregnancies with fibroids. MATERIALS AND

methodsWe realize a prospective study that includes 57 patients with fibroids in pregnancy diagnosed in January 2017-June 2019. We analyze the number, the location and the growth of fibroids during pregnancy and the maternal and fetal outcome. We appreciate the bleeding in patients with a myomectomy and without a myomectomy during CS, using hemoglobin values before and after birth.

resultsMost of the patients present single fibroids that are 30-160 mm in size, located on the anterior uterine wall. Vaginal delivery is used in 7% of women, whereas 85.96% deliver by CS. In addition, 68% of fibroids are diagnosed in the first trimester. In most cases, the fibroid has maximum growth in the second trimester of pregnancy. The myomectomy rate for fibroids during CS is 24.48. Hemoglobin values showed no statistically significant difference between the two groups with and without myomectomy. The operating time is double for the group with a myomectomy associated with a CS. The results of the obstetric outcomes are abortion in 7% of all patients, whereas premature delivery and births at term are 9.43% and 90.57%, respectively.

conclusionsThe decision of performing a myomectomy during pregnancy can be a challenge and must be performed for selected cases. This procedure may have several benefits, such as avoiding another operation to remove fibroids.

Indexed as

myomectomyobstetric outcomepregnancyultrasounduterine fibroid

Identifiers

PMID35627994
PMCPMC9141014
OpenAlexW4229041450

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.